Skip to main content
Clinical Trials/NCT04554927
NCT04554927
Recruiting
Not Applicable

Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer

Centre Francois Baclesse1 site in 1 country438 target enrollmentSeptember 3, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Web-application
Sponsor
Centre Francois Baclesse
Enrollment
438
Locations
1
Primary Endpoint
Observance of hormontherapy
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.

Registry
clinicaltrials.gov
Start Date
September 3, 2020
End Date
December 31, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Centre Francois Baclesse
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient \> 18 years old
  • Breast cancer patient candidate for adjuvant hormone therapy
  • Mastery of the French language
  • Patient with a cell phone and an Internet connection
  • Patient able to use a computer, smartphone, or tablet.
  • Patient affiliated to a social security system
  • Signing of informed consent prior to any specific study-related procedure

Exclusion Criteria

  • Patient who has previously received hormone therapy for cancer.
  • Patient not trained in the use of the application
  • Any associated medical or psychiatric condition that might compromise the patient's ability to participate in the study
  • Patients with locoregional or metastatic recurrence
  • Other history of cancer.
  • Patient deprived of liberty, under guardianship or curatorship
  • Simultaneous participation in a therapeutic clinical trial or other clinical study involving a connected tool
  • Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons

Outcomes

Primary Outcomes

Observance of hormontherapy

Time Frame: 18 months

Evaluate the benefit of a web-based application on hormone therapy compliance (Morisky questionnary; answer Yes or No; 8 questions)

Secondary Outcomes

  • Quality of life with self questionnaires(18 months)

Study Sites (1)

Loading locations...

Similar Trials